Skip to search formSkip to main contentSkip to account menu

Bivalent Meningococcal Vaccine

Known as: Meningococcal Vaccine, Bivalent 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
ABSTRACT Bivalent rLP2086 (Trumenba), a vaccine for prevention of Neisseria meningitidis serogroup B (NmB) disease, was licensed… 
Review
2018
Review
2018
ABSTRACT Introduction: Given the characteristics of meningococcal carriage and transmission and the sudden, often severe onset… 
Review
2016
Review
2016
ABSTRACT Neisseria meningitidis is a common cause of bacterial meningitis, often leading to permanent sequelae or death. N… 
2016
2016
ABSTRACTTrumenba (bivalent rLP2086) is a vaccine licensed for the prevention of meningococcal meningitis disease caused by… 
2016
2016
Key points Concomitant administration of bivalent rLP2086 (Trumenba [Pfizer, Inc] and diphtheria, tetanus, and acellular… 
2010
2010
ABSTRACT The Arenaviridae are a diverse and globally distributed collection of viruses that are maintained primarily by rodent… 
Highly Cited
1996
Highly Cited
1996
OBJECTIVE To assess the safety and immunogenicity of a bivalent serogroups A/C meningococcal oligosaccharide-protein conjugate… 
1977
1977
During winter 75/76 (from February 1 to March 31) we got the opportunity to follow the incidence of an influenza epidemic that…